Syndax Pharmaceuticals Inc (SNDX) — Working Capital to Net Assets Ratio
Syndax Pharmaceuticals Inc (SNDX) has a Working Capital to Net Assets ratio of 3810.6% as of June 2026. Working capital of $575.36 Million (current assets of $675.04 Million minus current liabilities of $99.68 Million) is measured against net assets of $15.10 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Syndax Pharmaceuticals Inc Working Capital to Net Assets (2011–2025)
This chart shows how Syndax Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 3810.6%, reflecting working capital of $575.36 Million against net assets of $15.10 Million USD. Explore Syndax Pharmaceuticals Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Working Capital to Net Assets for Syndax Pharmaceuticals Inc (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Syndax Pharmaceuticals Inc from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Syndax Pharmaceuticals Inc (SNDX) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 631.2% | $407.96 Million | $64.63 Million | $528.08 Million | $120.12 Million | ▲ +457.9 pp |
| 2024 | 173.4% | $499.51 Million | $288.12 Million | $603.06 Million | $103.55 Million | ▲ +79.0 pp |
| 2023 | 94.3% | $522.78 Million | $554.20 Million | $580.88 Million | $58.10 Million | ▼ -4.2 pp |
| 2022 | 98.6% | $460.72 Million | $467.45 Million | $489.79 Million | $29.07 Million | ▼ -6.2 pp |
| 2021 | 104.7% | $427.71 Million | $408.37 Million | $448.40 Million | $20.68 Million | ▼ -6.3 pp |
| 2020 | 111.0% | $279.99 Million | $252.19 Million | $298.86 Million | $18.87 Million | ▼ -28.1 pp |
| 2019 | 139.1% | $43.96 Million | $31.60 Million | $62.33 Million | $18.37 Million | ▲ +12.4 pp |
| 2018 | 126.8% | $67.24 Million | $53.05 Million | $83.35 Million | $16.11 Million | ▲ +14.0 pp |
| 2017 | 112.8% | $117.64 Million | $104.32 Million | $133.44 Million | $15.80 Million | ▼ -3.9 pp |
| 2016 | 116.6% | $98.14 Million | $84.14 Million | $108.51 Million | $10.37 Million | ▼ -8.0 pp |
| 2015 | 124.7% | $83.16 Million | $66.70 Million | $88.01 Million | $4.85 Million | ▲ +161.4 pp |
| 2014 | -36.7% | $2.10 Million | $-5.72 Million | $12.44 Million | $10.35 Million | ▼ -136.4 pp |
| 2013 | 99.7% | $11.81 Million | $11.85 Million | $14.54 Million | $2.73 Million | ▲ +16.5 pp |
| 2012 | 83.2% | $-24.37 Million | $-29.29 Million | $735.00K | $25.10 Million | ▲ +35.9 pp |
| 2011 | 47.3% | $-9.02 Million | $-19.05 Million | $4.39 Million | $13.41 Million | — |